Abbott plans to spin out its nutrition business

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 21 Oct, 16:45 UTC

Abbott, which also cut its 2026 sales growth guidance, said company sales will total $42 billion following the separation.